Transcutaneous neurostimulator tVNS® E

for vagus nerve stimulationself-adjusting

The world is changing so are treatments! tVNS® E is a medical device, CE Certified according to MDR EU 2017/745, indicated for treatment of epilepsy, depression, autism, anxiety, atrial fibrillation, Crohn’s disease(IBD), cognitive impairment, migraine, systemic sclerosis, sleep disorder, Prader-Willi syndrome, Parkinson’s and tinnitus. tVNS® E stimulates the branch of the vagus nerve via a special ear electrode, in the auricle through the skin with gentle electrical impulses (neuromodulation). Signals are passed on to the brain via special nerve fibers: first in the brain stem and then in higher centers. This alleviates symptoms of sympathovagal imbalance, for example reducing seizures in epilepsy. The treatment with tVNS® E is applied by patients independently. It has been used by thousands of patients and is a treatment with very few side effects. With the innovative tVNS® patient app, you can track your treatment at any time and share your data with your doctor. In addition, the tVNS® patient app enables us to continuously improve our technology and optimize your treatment. The tVNS® Patient App is available now in the Google Play Store and in the Apple App Store (EU-only). Features : - Non-Surgical Treatment tVNS-L ® offers vagus treatment option in full patient control, which does not require surgery and does not involve invasive risks. - Minimal Side Effects tVNS® has minimal side effects compared to drug treatments and invasive treatmens. - Remote Delivery Device delivery, regular follow-up and any update on the therapy are possible remotely without leaving your home. - Pediatric Flexibility Approved for children aged 3 and over.